The PD-1 Pembrolizumab Biosimilar MAb (HDBS0006) is a monoclonal antibody designed for research involving PD-1, a cell surface receptor that plays a key role in regulating immune responses. The antibody is highly specific and reactive with human samples, making it ideal for use in various research applications including Western blotting and immunohistochemistry.PD-1, also known as programmed cell death protein 1, is an immune checkpoint protein that inhibits T cell activation and plays a critical role in maintaining immune tolerance.
Blockade of PD-1 has shown promise in the treatment of various cancers by restoring T cell function and activating anti-tumor immune responses. The Anti-PD-1 Pembrolizumab Biosimilar MAb (HDBS0006) is a valuable tool for studying the role of PD-1 in cancer immunotherapy and for developing novel therapies that target this immune checkpoint pathway. Its high specificity and sensitivity make it a reliable reagent for researchers working in the fields of immunology, oncology, and drug development.
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
MK-3475
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG4
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
